Cost-effectiveness of a voucher-based intervention for smoking cessation

American Journal of Drug and Alcohol Abuse

Volumn 42, Issue 3, 2016, Pages 296-305

  López Núñez, Carla ^a   Alonso Pérez, Fernando ^a   Pedrosa, Ignacio ^a   Secades Villa, Roberto ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

community setting; contingency management; Cost effectiveness; smoking cessation

Indexed keywords

COTININE;

ADULT; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FINANCIAL MANAGEMENT; FOLLOW UP; HEALTH CARE COST; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING CESSATION; VOUCHER BASED INTERVENTION; BEHAVIOR THERAPY; COGNITIVE THERAPY; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BEHAVIOR THERAPY; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; SMOKING CESSATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84944930425     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1081913     Document Type: Article

References (63)

1. M.Prendergast, D.Podus, J.Finney, L.Greenwell, J.Roll Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006;101:1546–1560.
2. M.Stitzer, N.Petry Contingency management for treatment of substance abuse. Ann Rev Clin Psychol 2006;2:411–434.
3. K.Tracy, T.Babuscio, C.Nich, B.Kiluk, K.M.Carroll, N.M.Petry, B.J.Rounsaville Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse 2007;33:253–258.
4. S.T.Higgins, K.Silverman, S.H.Heil Contingency management in substance abuse treatment. New York, NY: The Guilford Press; 2008.
5. D.M.Ledgerwood Contingency management for smoking cessation: where do we go from here? Curr Drug Abuse Rev 2008;1:340–349.
6. S.C.Sigmon, M.E.Patrick The use of financial incentives in promoting smoking cessation. Prev Med 2012;55(Suppl.):S24–32.
7. N.M.Petry, S.M.Alessi, D.M.Ledgerwood Contingency management delivered by community therapists in outpatient settings. Drug Alcohol Depend 2012;122:86–92.
8. S.McPherson, R.R.Packer, J.M.Cameron, D.N.Howell, J.M.Roll Biochemical marker of use is a better predictor of outcomes than self-report metrics in a contingency management smoking cessation analog study. Am J Addict 2014;23:15–20.
9. S.M.Alessi, G.J.Badger, S.T.Higgins An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp Clin Psychopharmacol 2004;12:276–287.
10. S.H.Heil, J.W.Tidey, H.W.Holmes, G.J.Badger, S.T.Higgins A contingent payment model of smoking cessation: effects on abstinence and withdrawal. Nicotine Tob Res 2003;5:205–213.
11. J.Dallery, I.M.Glenn, B.R.Raiff An internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend 2007;86:230–238.
12. R.J.Lamb, K.C.Kirby, A.R.Morral, G.Galbicka, M.Y.Iguchi Shaping smoking cessation in hard-to-treat smokers. J Consult Clin Psychol 2010;78:62–71.
13. S.M.Alessi, N.M.Petry, J.Urso Contingency management promotes smoking reductions in residential substance abuse patients. J Appl Behav Anal 2008;41:617–622.
14. E.Robles, C.C.Crone, L.Whiteside-Mansell, N.A.Conners, P.A.Bokony, L.L.Worley, D.E.McMillan Voucher-based incentives for cigarette smoking reduction in a women’s residential treatment program. Nicotine Tob Res 2005;7:111–117.
15. G.García-Fernández, R.Secades-Villa, O.García-Rodríguez, H.Álvarez-López, J.R.Fernández-Hermida, S.Fernández-Artamendi, S.T.Higgins Long-term benefits of adding incentives to the community reinforcement approach for cocaine dependence. Eur Addict Res 2011;17:139–145.
16. S.Krishnan-Sarin, A.M.Duhig, S.A.McKee, T.J.McMahon, T.Liss, A.McFetridge, D.A.Cavallo Contingency management for smoking cessation in adolescent smokers. Exp Clin Psychopharmacol 2006;14:306–310.
17. T.O.Tevyaw, S.M.Colby, J.W.Tidey, C.W.Kahler, D.J.Rohsenow, N.P.Barnett, C.J.Gwaltney, et al. Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob Res 2009;11:739–749.
18. R.Donatelle, D.Hudson, S.Dobie, A.Goodall, M.Hunsberger, K.Oswald Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob Res 2004;6(Suppl. 2):S163–179.
19. S.T.Higgins, Y.Washio, S.H.Heil, L.J.Solomon, D.E.Gaalema, T.M.Higgins, I.M.Bernstein Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med 2012;55:S33–40.
20. J.W.Tidey, D.J.Rohsenow, G.B.Kaplan, R.M.Swift, N.Reid Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) 2011;217:279–287.
21. K.G.Volpp, A.G.Levy, D.A.Asch, J.A.Berlin, J.J.Murphy, A.Gomez, H.Sox, et al. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev 2006;15:12–18.
22. K.M.Carroll, B.J.Rounsaville A perfect platform: combining contingency management with medications for drug abuse. Am J Drug Alcohol Abuse 2007;33:343–365.
23. S.M.Alessi, T.Hanson, M.Wieners, N.M.Petry Low-cost contingency management in community clinics: delivering incentives partially in group therapy. Exp Clin Psychopharmacol 2007;15:293–300.
24. B.Hartzler, S.J.Lash, J.M.Roll Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend 2012;122:1–10.
25. N.M.Petry, J.Tedford, M.Austin, C.Nich, K.M.Carroll, B.J.Rounsaville Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 2004;99:349–360.
26. N.M.Petry, J.M.Peirce, M.L.Stitzer, J.Blaine, J.M.Roll, A.Cohen, J.Obert, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005;62:1148–1156.
27. J.M.Roll, J.E.Chudzynski, G.Richardson Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions. Am J Drug Alcohol Abuse 2005;31:21–33.
28. O.García-Rodríguez, R.Secades-Villa, S.T.Higgins, J.R.Fernández-Hermida, J.L.Carballo Financing a voucher program for cocaine abusers through community donations in Spain. J Appl Behav Anal 2008;41:623–628.
29. T.A.Olmstead, J.L.Sindelar, N.M.Petry Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend 2007;87:175–182.
30. T.A.Olmstead, N.M.Petry The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend 2009;102:108–115.
31. J.L.Sindelar, T.A.Olmstead, J.M.Peirce Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007;102:1463–1471.
32. K.Fiscella, P.Franks Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA 1996;275:1247–1251.
33. M.von Wartburg, V.Raymond, P.E.Paradis The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada. Int J Clin Pract 2014;68:639–646.
34. S.ESSmit, E.SMEvers, H.de Vries, C.Hoving Cost-effectiveness and cost-utility of Internet-based computer tailoring for smoking cessation. J Med Internet Res 2013;15:e57.
35. M.W.Smith, L.C.An, S.S.Fu, D.B.Nelson, A.M.Joseph Cost-effectiveness of an intensive telephone-based intervention for smoking cessation. J Telemed Telecare 2011;17:437–440.
36. M.Y.Smith, J.Cromwell, J.DePue, B.Spring, W.Redd, M.Unrod Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care. Manag Care 2007;16:48–55.
37. A.L.Graham, Y.J.Chang, Y.Fang, N.K.Cobb, D.S.Tinkelman, R.S.Niaura, D.B.Abrams, et al. Cost-effectiveness of internet and telephone treatment for smoking cessation: an economic evaluation of The iQUITT Study. Tob Control 2013;22(6).
38. N.E.Stanczyk, E.S.Smit, D.N.Schulz, H.de Vries, C.Bolman, J.W.Muris, S.M.Evers An economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trial. PLoS One 2014;9(10).
39. X.Castañal-Canto, M.V.Martín-Miguel, C.Hervés-Beloso, S.Pérez-Cachafeiro, M.M.Espinosa-Arévalo, J.L.Delgado-Martín Working with our smoker patients in primary care. Analysis of cost-effectiveness. Aten Primaria 2012;44:659–666.
40. J.S.White, W.H.Dow, S.Rungruanghiranya Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand. Am J Prev Med 2013;45:533–542.
41. R.Secades-Villa, O.García-Rodríguez, C.López-Núñez, F.Alonso-Pérez, J.R.Fernández-Hermida Contingency management for smoking cessation among treatment-seeking patients in a community setting. Drug Alcohol Depend 2014;140:63–68.
42. E.Becoña, F.L.Vázquez Does using relapse prevention increase the efficacy of a program for smoking cessation? An empirical study. Psychol Rep 1997;81:291–296.
43. R.Secades-Villa, F.Alonso-Pérez, O.García-Rodríguez, J.R.Fernández-Hermida Effectiveness of three intensities of smoking cessation treatment in primary care. Psychol Rep 2009;105:747–758.
44. M.F.Drummond, M.J.Sculpher, G.W.Torrance, B.O’Brien, G.L.Stoddart Methods for the economic evaluation of health care programs, 3rd ed. Oxford, UK: Oxford University Press; 2005.
45. M.R.Gold, J.E.Siegel, L.B.Russell, M.C.Weinstein Cost-effectiveness in health and medicine. Oxford, UK: Oxford University Press; 1996.
46. J.Sindelar, B.Elbel, N.M.Petry What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007;102:309–316.
47. E.Fenwick, K.Claxton, M.Sculpher Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779–787.
48. E.Fenwick, S.Byford A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:106–108.
49. R.M.Nixon, D.Wonderling, R.D.Grieve Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared. Health Econ 2010;19:316–333.
50. A.R.Willan Analysis, sample size, and fewer for estimating incremental net health benefit from clinical trial data. Control Clin Trials 2001;22:228–237.
51. C.E.Metz, B.A.Herman, J.H.Shen Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 1998;17:1033–1053.
52. D.Cohen, M.F.Alam, P.S.Jarvis An analysis of the economic impact of smoking cessation in Europe. BMC Public Health 2013;13:390.
53. E.Nohlert, A.R.Helgason, P.Tillgren, A.Tegelberg, P.Johansson Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial. Nicotine Tob Res 2013;15:1519–1527.
54. J.B.Wasserfallen, P.Digon, J.Cornuz Medical and pharmacological direct costs of a 9-week smoking cessation programme. Eur J Prev Cardiol 2012;19:565–570.
55. L.C.Christenhusz, R.Prenger, M.E.Pieterse, E.R.Seydel, van der Palen J. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients. Nicotine Tob Res 2012;14:657–663.
56. R.Prenger, M.E.Pieterse, L.M.Braakman-Jansen, J.van der Palen, L.C.Christenhusz, E.R.Seydel Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions. Eur J Health Econ 2013;14:297–306.
57. J.R.Banegas, L.Díez-Gañán, B.Bañuelos-Marco, J.González-Enríquez, F.Villar-Álvarez, J.M.Martín-Moreno, R.Córdoba-García, et al. Smoking-attributable deaths in Spain, 2006. Med Clin (Barc) 2011;136:97–102.
58. E.Becoña, M.A.Vázquez, M.C.Míguez, Fernández del Río E, López-Durán A, Martínez Ú, Piñeiro B. Smoking habit profile and health-related quality of life. Psicothema 2013;25:421–426.
59. K.Bolin Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models. Pharmacoeconomics 2012;30:551–564.
60. J.González-Enríquez, T.Salvador-Llivina, A.López-Nicolás, Antón de las Heras E, Musin A, Fernández E, García M, et al. The effects of implementing a smoking cessation intervention in Spain on morbidity, mortality and health care costs. Gac Sanit 2002;16:308–317.
61. J.A.Sacristán, J.Oliva, J.Del Llano, L.Prieto, J.L.Pinto What is an efficient health technology in Spain? Gac Sanit 2002;16:334–343.
62. J.M.Rodríguez Barrios, F.Pérez Alcántara, C.Crespo Palomo, P.González García, Antón de las Heras E, Brosa Riestra M. The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications. Eur J Health Econ 2012;13:723–740.
63. K.C.Kirby, C.M.Carpenedo, M.L.Stitzer, K.L.Dugosh, N.M.Petry, J.M.Roll, M.E.Saladin, et al. Is exposure to an effective contingency management intervention associated with more positive provider beliefs? J Subst Abuse Treat 2012;42:356–365.